Alnylam Pharmaceuticals

Important Upgrade Notice:

At 9 pm Central, Sunday 2/16/2020, we launched the following tools as Phase One of our Premium Plus service (full service package still under development):

1) Customizable Scrolling Ticker
2) Portfolio Manager
3) Stock-specific News & Trading Email Alert Notifications

These products are immediately available to Precious Metal & Gemstone Patrons.

To watch a tutorial on the "regular" site, click here. On "premium," click here.

Links: Y! Homepage

ALNY / Message Board

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
34762	SA article	GN	Steve_382		0	2/15/2020 12:39:11 PM

34761	Personnel change	GN	Steve_382		0	2/12/2020 3:05:35 PM

34760	Genetic testing for Givlari	GN	Steve_382		0	2/11/2020 6:53:28 PM

34759	Nomura raises PT to $75	GN	Steve_382		0	2/11/2020 11:30:42 AM

34758	Alnylam gets CHMP backing for second gene-silencing drug Givlaari	GN	jerrykrause		0	2/5/2020 12:12:02 PM

34757	Alnylam Receives Positive CHMP Opinion for GIVLAARI™ (givosiran)	GN	Steve_382		0	1/31/2020 12:04:05 PM

34756	Re: Inclisiran and other revenues sources	GN	Steve_382		3	1/17/2020 9:47:50 PM

34755	Endpoints article on Inclisiran	GN	Steve_382		2	1/14/2020 9:51:34 AM

34754	Re: Inclisiran and other revenues sources	GN	biochemyst		1	1/8/2020 1:25:30 PM

34753	Inclisiran and other revenues sources	GN	Steve_382		1	1/8/2020 10:34:30 AM


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2019 Investorvillage.com. All rights reserved. User Agreement